VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations The Augusta Way
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is: Does the modified programming of the VNS reduce seizures faster than the standard programming? Participants in both groups will: 1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Subjects who are clinically determined to be candidates for VNS implantation for seizure control
• Subject/legally authorized representative able to provide informed consent.
Locations
United States
Georgia
Wellstar MCG Hospital
RECRUITING
Augusta
Contact Information
Primary
Brandy Quarles, MPH
bquarles@augusta.edu
706-721-0390
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2030-12-30
Participants
Target number of participants: 80
Treatments
Experimental: Augusta Way
Modified programming of VNS that provides rapid titration
Active_comparator: Control
Standard of care VNS programming
Sponsors
Leads: Fernando Vale
Collaborators: Augusta University